Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#CancerResearch--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the ...

Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...

The Angelika Amon research building is named after a Viennese pioneer in cell biology who was closely connected with Boehringer Ingelheim. Image credit: Boehringer Ingelheim. Boehringer Ingelheim has ...